Social-Cultural Approaches to Microbial Life in an Era of Antimicrobial Resistance
Lead Research Organisation:
UNIVERSITY OF EXETER
Department Name: Geography
Abstract
We live in a moment where newly emerging infectious diseases, multi-drug resistant infections and new scientific fields and practices such as synthetic biology are unravelling long held assumptions about how we think about and engage with microbial life forms. Antibacterial resistance in particular, is one of a number of contemporary health challenges which is unravelling the taken-for-grantedness of modern medicine and modern life (Hutchinson, 2016). By 2050 it is predicted that increasing rates of drug reistant infections may contribute to as many as 10 million deaths per year (O'Neill, 2016).
Antibacterial resistance is often thought of in scientific or technical terms (Smith, 2015). But ABR is as much of a social and cultural issue as it is a technical and biological one. In the 1970s the sociologist Tanya Stivers pointed to the ways in which patient pressure and cultural norms of prescribing shape antibiotic use and health outcomes in the GP clinic (Stivers, 2007). More recently, anthropologists and sociologists have moved beyond the GP clinic and have examined the role of medical culture in shaping ABR in hospital settings and the social-cultural dynamics that drive ABR in low income countries (cf Broom et al, 2016; Roess et al, 2015). The aim of this fellowship is to build upon the knowledge and isnights that I have gained during my PhD and postdoctoral research and to develop of a conceptual account of, as well as a methodological agenda for engaging with, the social dimensions of this contemporary moment of biosocial complexity and change.
As part of this fellowship I will trace the shifting contours of the contemporary biosocial moment. I will map out how and why social innovation matters. Predominating approaches to tackling ABR often focus on technological solutions including new and better drugs as well as improved diagnostics. But this approach fails to recognise that technical innovations are always put to work in a social contexts. We are beginning to see, for example, that diagnostic tests - key technological tools designed to result in better diagnosis and the more judicious use of antibiotics - are intersecting with different care models and social pressures in ways which facilitate their overuse and which can compound, rather than help to tackle, the ABR challenge (Ledingham et al, 2018).
Through the development of a science-facing report I will also outline how different social science methods can be brought to bear on the ABR challenge. There is still a tendency to position social science as being primarily concerned with accessing beliefs and social opinions. But beliefs and opinions are rarely translated seamlessly into practice. This is because beliefs and opinions are diffracted as they encounter the thickness of social and cultural norms and contexts.
This is an engaged programme of work and throughout the course of the fellowship I will engage with research end users and diverse stakeholders including WHO Europe and scientists working to address the challenge of ABR. I will organise a day event drawing together scientists and social scientists from across the SWDTP as well as non-academic bodies in order to explore how social scientsts and scientists might work together and collaborate in experimental and new ways on the challenge of ABR.
Antibacterial resistance is often thought of in scientific or technical terms (Smith, 2015). But ABR is as much of a social and cultural issue as it is a technical and biological one. In the 1970s the sociologist Tanya Stivers pointed to the ways in which patient pressure and cultural norms of prescribing shape antibiotic use and health outcomes in the GP clinic (Stivers, 2007). More recently, anthropologists and sociologists have moved beyond the GP clinic and have examined the role of medical culture in shaping ABR in hospital settings and the social-cultural dynamics that drive ABR in low income countries (cf Broom et al, 2016; Roess et al, 2015). The aim of this fellowship is to build upon the knowledge and isnights that I have gained during my PhD and postdoctoral research and to develop of a conceptual account of, as well as a methodological agenda for engaging with, the social dimensions of this contemporary moment of biosocial complexity and change.
As part of this fellowship I will trace the shifting contours of the contemporary biosocial moment. I will map out how and why social innovation matters. Predominating approaches to tackling ABR often focus on technological solutions including new and better drugs as well as improved diagnostics. But this approach fails to recognise that technical innovations are always put to work in a social contexts. We are beginning to see, for example, that diagnostic tests - key technological tools designed to result in better diagnosis and the more judicious use of antibiotics - are intersecting with different care models and social pressures in ways which facilitate their overuse and which can compound, rather than help to tackle, the ABR challenge (Ledingham et al, 2018).
Through the development of a science-facing report I will also outline how different social science methods can be brought to bear on the ABR challenge. There is still a tendency to position social science as being primarily concerned with accessing beliefs and social opinions. But beliefs and opinions are rarely translated seamlessly into practice. This is because beliefs and opinions are diffracted as they encounter the thickness of social and cultural norms and contexts.
This is an engaged programme of work and throughout the course of the fellowship I will engage with research end users and diverse stakeholders including WHO Europe and scientists working to address the challenge of ABR. I will organise a day event drawing together scientists and social scientists from across the SWDTP as well as non-academic bodies in order to explore how social scientsts and scientists might work together and collaborate in experimental and new ways on the challenge of ABR.
Organisations
Publications
Hartley S
(2019)
Knowledge engagement in gene drive research for malaria control.
in PLoS neglected tropical diseases
Ledingham K
(2021)
Transformation and slippage in co-production ambitions for global technology development: The case of gene drive
in Environmental Science & Policy
Ledingham K
(2021)
Transformation and slippage in co-production ambitions for global technology development: The case of gene drive
in Environmental Science and Policy
| Description | On-going collaboration and informing of industry/policy practice on the importance of social-cultural dynamics in relation to contemporary microbial health challenges (including antibiotic resistance and malaria) and their associated technological 'solutions' (e.g. gene drive). |
| Exploitation Route | Development of research and policy processes which place the social and the cultural at the centre of interventions for change. |
| Sectors | Environment Healthcare Government Democracy and Justice |
| Description | During the course of this early career one year fellowship I have presented and engaged with a variety of industry and policy bodies including WHO Europe, a leading technology developer & the Baltic authorities for the regulation of GMOs. This has been part of a wider effort to consider the 'social' and the 'cultural' dynamics that impact on a) how health challenges such as ABR and malaria arise and are understood in the first instance and b) the ways in which potential solutions/innovations are capacitated or not in given social-political-cultural settings (e.g. new capacities in genetic engineering). This has led to ongoing collaborations in progress. |
| Impact Types | Policy & public services |
| Description | Please see policy, industry and advisory activities detailed in 'engagement' section |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Please see policy, industry and advisory activities detailed in 'engagement' section |
| Description | Global gene drive governance for climate adaptation and conservation |
| Amount | £29,967 (GBP) |
| Organisation | University of Exeter |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 02/2020 |
| End | 07/2020 |
| Description | Talking about gene drive: an exploration of language to enable understanding and deliberation in Africa, Europe, North America and Australasia |
| Amount | £100,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2019 |
| End | 11/2020 |
| Description | Writing the Social Sciences of Microbial Life |
| Amount | £3,000 (GBP) |
| Organisation | The Landmark Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2020 |
| End | 02/2020 |
| Description | Advising Ethics Advisory Board, Ghana |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Presentation advising the ethics advisory board of a international tech developer (focusing on the manipulation of microbial life using gene drive). This tech developer may be the first to release gene drive organisms in sub-Saharan Africa, raising significant ethical and social questions and considerations. |
| Year(s) Of Engagement Activity | 2019 |
| Description | CRISPRCon Expert Panel |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | I moderated an hour long expert panel with a view to bringing out the importance of opening up the latest advances in science and microbial manipulation to tackle 'disease' to a much wider range of voices, concerns and interests. |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.youtube.com/watch?v=GsQbpUJcyiY |
| Description | Expert Panel European Public Health, Marseille |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk on why taking social-cultural dynamics seriously in the ABR challenge is key. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Presentation to European expert regulatory group (Baltic authorities) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Presentation to the Baltic Authorities on how they can incorporate social-cultural considerations into the risk assessment practices of genetically modified organisms. |
| Year(s) Of Engagement Activity | 2019 |
| Description | WHO Europe HQ (Copenhagen) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | During this visit I worked with the WHO Cultural Contexts of Health team based at WHO Europe - a small team working to embed an understanding of the importance of the 'social' and 'cultural' in impacting health outcomes. We discussed the key findings to have emerged from my WHO report and worked on an accompanying article to disseminate further the key points from the policy brief. I also participated in discussions with an Australian Institution looking to become a collaborating WHO centre by foregrounding the importance of the 'social' in the ABR challenge. |
| Year(s) Of Engagement Activity | 2019 |
| Description | WHO International Webinar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This was an international webinar designed for a varied audience and which called for a shift in treating antibiotic resistance not as a technical matter but as a fundamentally social one that needs addressing in a more holistic manner. The presentation provided key, digestible accounts of why culture and social dynamics need to be taken seriously in light of the ABR challenge and how they can provide resources and new possibilities for change. |
| Year(s) Of Engagement Activity | 2019 |
